San Diego, California–(Newsfile Corp. – April 20, 2021) – Tryp Therapeutics Inc. ( CSE: TRYP) (OTCQB: TRYPF) (“Tryp” or the “Company“), a pharmaceutical company focused on developing clinical-stage compounds for diseases with unmet medical needs, reported today on the Company’s significant progress since successfully completing its Initial Public Offering in December 2020. Tryp is advancing two…
